2,2-DiMethyl-6-nitro-3,4-dihydro-2H-1,4-benzoxazine, 97%
- $288.09 - $908.96
- Product name: 2,2-DiMethyl-6-nitro-3,4-dihydro-2H-1,4-benzoxazine, 97%
- CAS: 136545-11-4
- MF: C10H12N2O3
- MW: 208.21
- EINECS:
- MDL Number:MFCD03427728
- Synonyms:2,2-DiMethyl-6-nitro-3,4-dihydro-2H-1,4-benzoxazine, 97%;2,2-Dimethyl-6-nitro-3,4-dihydro-2H-benzo[b][1,4]oxazine;2,2-dimethyl-6-nitro-3,4-dihydro-1,4-benzoxazine;2H-1,4-Benzoxazine, 3,4-dihydro-2,2-dimethyl-6-nitro-
4 prices
Selected condition:
Brand
- Alichem
- Crysdot
- Sigma-Aldrich
Package
- 1g
- 5g
- ManufacturerAlichem
- Product number136545114
- Product description2,2-Dimethyl-6-nitro-3,4-dihydro-2h-benzo[b][1,4]oxazine
- Packaging1g
- Price$288.09
- Updated2021-12-16
- Buy
- ManufacturerAlichem
- Product number136545114
- Product description2,2-Dimethyl-6-nitro-3,4-dihydro-2h-benzo[b][1,4]oxazine
- Packaging5g
- Price$908.96
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11271771
- Product description2,2-DIMETHYL-6-NITRO-3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZINE 95+%
- Packaging1g
- Price$416
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product numberVBP00112
- Product description2,2-Dimethyl-6-nitro-3,4-dihydro-2H-benzo[b][1,4]oxazine
- Packaging1g
- Price$463
- Updated2023-06-20
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Alichem | 136545114 | 2,2-Dimethyl-6-nitro-3,4-dihydro-2h-benzo[b][1,4]oxazine | 1g | $288.09 | 2021-12-16 | Buy |
Alichem | 136545114 | 2,2-Dimethyl-6-nitro-3,4-dihydro-2h-benzo[b][1,4]oxazine | 5g | $908.96 | 2021-12-16 | Buy |
Crysdot | CD11271771 | 2,2-DIMETHYL-6-NITRO-3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZINE 95+% | 1g | $416 | 2021-12-16 | Buy |
Sigma-Aldrich | VBP00112 | 2,2-Dimethyl-6-nitro-3,4-dihydro-2H-benzo[b][1,4]oxazine | 1g | $463 | 2023-06-20 | Buy |
Properties
Safety Information
Symbol(GHS): | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | ||||||||||||||
Hazard statements: |
|
||||||||||||||
Precautionary statements: |
|